Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eller

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Infectious Diseases|January 19, 2010
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172)Hannah Kibuuka, Robert Kimutai, Leonard Maboko, et al.
Plos One|April 29, 2011
Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected UgandansMichael A Eller, Kim G Blom, Veronica D Gonzalez, et al.
Nature Communications|January 16, 2020
Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infectionKerri G Lal, Dohoon Kim, Margaret C Costanzo, et al.
Viruses|December 16, 2020
Longitudinal Analysis of Peripheral and Colonic CD161<sup>+</sup> CD4<sup>+</sup> T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment InitiationKerri G Lal, Yuwadee Phuang-Ngern, Suchada Suhkumvittaya, et al.
Frontiers in Immunology|December 29, 2022
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmissionBrittani M Barrows, Shelly J Krebs, Ningbo Jian, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2021
Preferential and persistent impact of acute HIV-1 infection on CD4<sup>+</sup> iNKT cells in colonic mucosaDominic Paquin-Proulx, Kerri G Lal, Yuwadee Phuang-Ngern, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2019
Terminal Effector CD8 T Cells Defined by an IKZF2<sup>+</sup>IL-7R<sup>-</sup> Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular CytotoxicityProssy Naluyima, Kerri G Lal, Margaret C Costanzo, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Vaccines|May 25, 2024
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical TrialJulie A Ake, Kristopher Paolino, Jack N Hutter, et al.
Plos Pathogens|April 14, 2018
Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV diseaseMarcus Buggert, Son Nguyen, Laura M McLane, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Infectious Diseases|January 19, 2010
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172)Hannah Kibuuka, Robert Kimutai, Leonard Maboko, et al.
Plos One|April 29, 2011
Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected UgandansMichael A Eller, Kim G Blom, Veronica D Gonzalez, et al.
Nature Communications|January 16, 2020
Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infectionKerri G Lal, Dohoon Kim, Margaret C Costanzo, et al.
Viruses|December 16, 2020
Longitudinal Analysis of Peripheral and Colonic CD161<sup>+</sup> CD4<sup>+</sup> T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment InitiationKerri G Lal, Yuwadee Phuang-Ngern, Suchada Suhkumvittaya, et al.
Frontiers in Immunology|December 29, 2022
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmissionBrittani M Barrows, Shelly J Krebs, Ningbo Jian, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2021
Preferential and persistent impact of acute HIV-1 infection on CD4<sup>+</sup> iNKT cells in colonic mucosaDominic Paquin-Proulx, Kerri G Lal, Yuwadee Phuang-Ngern, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2019
Terminal Effector CD8 T Cells Defined by an IKZF2<sup>+</sup>IL-7R<sup>-</sup> Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular CytotoxicityProssy Naluyima, Kerri G Lal, Margaret C Costanzo, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Vaccines|May 25, 2024
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical TrialJulie A Ake, Kristopher Paolino, Jack N Hutter, et al.
Plos Pathogens|April 14, 2018
Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV diseaseMarcus Buggert, Son Nguyen, Laura M McLane, et al.
Pageof 15